About Alpenglow Biosciences
Alpenglow Biosciences is a company based in Seattle (United States) founded in 2014.. Alpenglow Biosciences has raised $6.38 million across 6 funding rounds from investors including HHS and Dynamk Capital. Alpenglow Biosciences offers products and services including Aurora 3D Spatial Biology Solution and 3D Assay Service. Alpenglow Biosciences operates in a competitive market with competitors including PathAI, Deepcell, Aignostics, Pictor Labs and Neko Health, among others.
- Headquarter Seattle, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$96.53 K (USD)0as on Jul 31, 2023
-
Net Profit
$68.89 K (USD)0as on Jul 31, 2023
-
EBITDA
-
Total Equity Funding
$6.38 M (USD)
in 6 rounds
-
Latest Funding Round
$1.8 M (USD), Series A
Mar 07, 2024
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alpenglow Biosciences
Alpenglow Biosciences offers a comprehensive portfolio of products and services, including Aurora 3D Spatial Biology Solution and 3D Assay Service. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for 3D tissue imaging and AI analysis in medical research
Service for advanced tissue analysis in dermatology and oncology applications
Unlock access to complete
Unlock access to complete
Funding Insights of Alpenglow Biosciences
Alpenglow Biosciences has successfully raised a total of $6.38M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $1.8 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series A — $1.8M
-
First Round
First Round
(05 Sep 2020)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Series A - Alpenglow Biosciences | Valuation |
investors |
|
| Apr, 2022 | Amount | Grant - Alpenglow Biosciences | Valuation |
investors |
|
| Sep, 2021 | Amount | Grant - Alpenglow Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alpenglow Biosciences
Alpenglow Biosciences has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS and Dynamk Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in life sciences innovation is facilitated by Dynamk Capital.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alpenglow Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Alpenglow Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alpenglow Biosciences Comparisons
Competitors of Alpenglow Biosciences
Alpenglow Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Deepcell, Aignostics, Pictor Labs and Neko Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| domain | founded_year | HQ Location |
AI-powered single cell classification and isolation technology for clinical research
|
|
| domain | founded_year | HQ Location |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| domain | founded_year | HQ Location |
AI-based tools for pathological image analysis are provided to labs.
|
|
| domain | founded_year | HQ Location |
Platform offering solutions for preventive health scans
|
|
| domain | founded_year | HQ Location |
Imaging systems and AI software for microscopes are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Alpenglow Biosciences
Frequently Asked Questions about Alpenglow Biosciences
When was Alpenglow Biosciences founded?
Alpenglow Biosciences was founded in 2014 and raised its 1st funding round 6 years after it was founded.
Where is Alpenglow Biosciences located?
Alpenglow Biosciences is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Who is the current CEO of Alpenglow Biosciences?
Nicholas Reder is the current CEO of Alpenglow Biosciences.
Is Alpenglow Biosciences a funded company?
Alpenglow Biosciences is a funded company, having raised a total of $6.38M across 6 funding rounds to date. The company's 1st funding round was a Grant of $269.31K, raised on Sep 05, 2020.
What is the annual revenue of Alpenglow Biosciences?
Annual revenue of Alpenglow Biosciences is $96.53K as on Jul 31, 2023.
What does Alpenglow Biosciences do?
Alpenglow Biosciences was founded in 2014 in Seattle, United States. Software solutions for 3D visualization of biological images are developed and supplied. AI-assisted tools are utilized by researchers to examine complex morphological structures within tissue samples. Operations are centered in the biotechnology sector, with services aimed at enhancing image analysis for scientific applications. The companys domain is alpenglowbiosciences.com.
Who are the top competitors of Alpenglow Biosciences?
Alpenglow Biosciences's top competitors include Aignostics, Pictor Labs and PathAI.
What products or services does Alpenglow Biosciences offer?
Alpenglow Biosciences offers Aurora 3D Spatial Biology Solution and 3D Assay Service.
Who are Alpenglow Biosciences's investors?
Alpenglow Biosciences has 2 investors. Key investors include HHS, and Dynamk Capital.